Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$216M |
| 2 |
Charter Communications
CHTR
|
+$192M |
| 3 |
SLB Ltd
SLB
|
+$79.3M |
| 4 |
IBM
IBM
|
+$70.2M |
| 5 |
Newell Brands
NWL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AFFX
Affymetrix Inc
AFFX
|
+$7.53B |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$447M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$229M |
| 4 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$208M |
| 5 |
SANDISK CORP
SNDK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.87% |
| 2 | Technology | 14.38% |
| 3 | Financials | 13.98% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3801
Arcadia Biosciences
RKDA
$386K
| $67K | ﹤0.01% |
33
-10
| -23% | -$16.7K |
2015 Q3
3 quarters
|
|
3802
Stereotaxis
STXS
$101M
| $67K | ﹤0.01% |
72,112
| – | – |
2013 Q2
12 quarters
|
|
|
SAUC
3803
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
| $67K | ﹤0.01% |
44,368
| – | – |
2013 Q3
11 quarters
|
|
3804
Harrow
HROW
$1.02B
| $66K | ﹤0.01% |
17,570
| – | – |
2015 Q3
3 quarters
|
|
3805
Arcturus Therapeutics
ARCT
$295M
| $65K | ﹤0.01% |
2,081
| – | – |
2016 Q1
1 quarter
|
|
3806
CareDx
CDNA
$3.28B
| $65K | ﹤0.01% |
15,112
| – | – |
2015 Q3
3 quarters
|
|
3807
Odyssey Marine Exploration
OMEX
$37.6M
| $65K | ﹤0.01% |
32,448
+4
| +0% | +$12 |
2013 Q2
12 quarters
|
|
|
CORV
3808
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $65K | ﹤0.01% |
12,725
| – | – |
2015 Q4
2 quarters
|
|
|
SBSA
3809
DELISTED
Spanish Broadcasting System Inc.
SBSA
| $65K | ﹤0.01% |
18,498
| – | – |
2013 Q2
12 quarters
|
|
3810
DELISTED
Altamira Therapeutics Ltd
CYTO
| – | – |
0
| – | – |
2016 Q1
1 quarter
|
|
|
MDLY
3811
DELISTED
Medley Management Inc
MDLY
| $64K | ﹤0.01% |
1,098
+25
| +2% | +$1.52K |
2016 Q1
1 quarter
|
|
3812
Phoenix New Media
FENG
$17.3M
| $63K | ﹤0.01% |
2,868
+741
| +35% | +$17.6K |
2016 Q1
1 quarter
|
|
3813
Phio Pharmaceuticals
PHIO
$10.4M
| – | – |
0
| – | – |
2014 Q1
9 quarters
|
|
|
NAUH
3814
DELISTED
National American University Holdings, Inc.
NAUH
| $63K | ﹤0.01% |
32,070
| – | – |
2013 Q2
12 quarters
|
|
|
GMAN
3815
DELISTED
Gordmans Stores, Inc.
GMAN
| $63K | ﹤0.01% |
49,557
| – | – |
2013 Q2
12 quarters
|
|
3816
Bloomia Holdings
TULP
$10.8M
| $62K | ﹤0.01% |
4,096
| – | – |
2013 Q2
12 quarters
|
|
|
WTT
3817
DELISTED
Wireless Telecom Group, Inc.
WTT
| $62K | ﹤0.01% |
46,661
| – | – |
2013 Q2
12 quarters
|
|
|
XIN
3818
DELISTED
Xinyuan Real Estate
XIN
| $61K | ﹤0.01% |
1,261
-222
| -15% | -$11.1K |
2016 Q1
1 quarter
|
|
|
MBII
3819
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $61K | ﹤0.01% |
74,484
-2,017
| -3% | -$1.56K |
2013 Q3
11 quarters
|
|
|
CXDC
3820
DELISTED
China XD Plastics Company Limited
CXDC
| $61K | ﹤0.01% |
19,221
| – | – |
2014 Q4
6 quarters
|
|
|
DAKP
3821
DELISTED
DAKOTA PLAINS HOLDINGS, INC. COMMON STOCK
DAKP
| $61K | ﹤0.01% |
555,860
| – | – |
2014 Q3
7 quarters
|
|
3822
SiNtx Technologies
SINT
$13.2M
| – | – |
0
| – | – |
2014 Q1
9 quarters
|
|
|
OBCI
3823
DELISTED
Ocean Bio-Chem Inc
OBCI
| $60K | ﹤0.01% |
26,292
| – | – |
2013 Q2
12 quarters
|
|
|
RESN
3824
DELISTED
Resonant Inc.
RESN
| $60K | ﹤0.01% |
13,701
| – | – |
2015 Q1
5 quarters
|
|
3825
Turtle Beach Corp
TBCH
$272M
| $59K | ﹤0.01% |
15,328
| – | – |
2013 Q2
12 quarters
|
|
Similar funds
Geode Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, down 2.4% from $188B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management withdrew a net $8.49B in Q2 2016, closing 127 positions and reducing 984 holdings. Its most notable exit was Affymetrix Inc, an estimated $7.53B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Geode Capital Management opened a new position in S&P Global worth $215M.
- Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
- Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
- Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
- Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53B.
- Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
- Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
- Geode Capital Management's portfolio value fell 2.4% quarter-over-quarter to $184B.
Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.